FAIRLAWN, Ohio—In industries where the goal posts are moving at a breathtaking pace—from the sweeping move toward electrification and sustainability to the packaging integrity of COVID vaccines—ripple effects can be felt in just about every related industry.
That includes the regulatory space, where companies like Altdorf, Switzerland-based Datwyler have to remain current with the pace of change, and then adapt to it.
And that is not easy, as speed-to-market continues to be a high priority for both the medical component manufacturer and the patient.
"We are engineering materials for a more sustainable world, and it is in this world where we need to have ideas come to fruition," said Roman Ventura, material applications manager at Datwyler Pharma Packaging in Middletown, Del. "We need to continue to bring value to our customers. And that is why I am excited to talk to you about robust testing."
Ventura spoke as part of the first day of the Healthcare Elastomers Conference, which took place May 8-9 in Fairlawn.
Datwyler Pharma Packaging manufactures elastomer components for injectable pharmaceutical packaging like syringes, stoppers, caps for vials, as well as rubber components for cartridges like those found in epinephrine injection pens.